Vanderbilt Scientist Annet Kirabo Wins 2026 Joseph A. Vita Award for Immune-Hypertension Discoveries

Annet Kirabo, D.V.M., Ph.D., FAHA, professor of medicine at Vanderbilt Health, will receive the 2026 Joseph A. Vita Award from the American Heart Association at its Scientific Sessions in Chicago, Nov. 6-9, 2026. The award, presented during the Opening Session on Nov. 7, honors a scientist whose research has significantly advanced cardiovascular biology or health within the past five years and whose work has been published in the Association's journals. The award is named after the late Joseph A. Vita, M.D., founding editor of the Journal of the American Heart Association (JAHA), and is selected by the editors-in-chief of the Association's 14 peer-reviewed journals.

Dr. Kirabo's discoveries have redefined the understanding of how the immune system contributes to high blood pressure. Her research demonstrated that lipid oxidation-derived protein adducts act as neoantigens that trigger antigen-presenting cell activation, T-cell responses, vascular dysfunction, and hypertension. This paradigm shift has opened new possibilities for preventing and treating hypertension and related cardiovascular and kidney diseases. Manesh R. Patel, M.D., FAHA, American Heart Association 2026-2027 volunteer president, said, “Her pioneering discoveries represent a paradigm shift in cardiovascular biology, reshaping our understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease.”

Today, Dr. Kirabo's laboratory combines immunology, vascular biology, genomics, metabolomics, and single-cell technologies to identify new therapeutic strategies. Her work spans from fundamental disease mechanisms to translational research with the potential to transform patient care. With more than 230 scientific publications and sustained NIH funding, she continues to influence investigators worldwide. Her research has been published in the Association's journals, including Hypertension, where she has served on the editorial board since 2018, and Circulation Research, where she has been an associate editor since 2019.

Beyond her research, Dr. Kirabo has been an active American Heart Association volunteer since 2009, serving on the Council on Hypertension Communications Committee, including as chair from 2022 to 2024, and on the Council Operations Committee since 2024. She has also reviewed research proposals and chaired sessions at scientific meetings. “I am deeply honored to receive the Joseph A. Vita Award from the American Heart Association, an organization that has supported my career from my predoctoral and postdoctoral fellowships through my development as an independent investigator,” Kirabo said. “Scientific discovery, mentorship and advancing new treatments for cardiovascular disease have been the primary focus of my career, and it is both rewarding and humbling to be recognized for it.”

Dr. Kirabo earned her doctor of veterinary medicine degree with honors from Makerere University in Uganda, a master of science in cell and molecular biology from St. Cloud State University, and a doctorate in physiology and functional genomics from the University of Florida. She completed postdoctoral training at Vanderbilt University, where she now leads an internationally recognized research program and mentors the next generation of cardiovascular scientists. Her commitment to mentorship and innovation continues to shape the future of cardiovascular research while expanding opportunities for emerging scientists around the world. The award highlights the critical role of immune mechanisms in hypertension, offering hope for new therapies that could impact millions affected by cardiovascular and kidney diseases. For more information, visit heart.org or stroke.org.